To confirm that all these evidences were due exclusively to the depletion of SET, we analyzed the levels of CIP2A, another endogenous inhibitor of PP2A [40], and SETBP1, which is known to stabilize SET at protein level in AML [41]. This evidence concerns the gene CIP2A and acute myeloid leukemia.